All articles
Does Mounjaro® Cause Constipation in Weight Loss Patients?
Reading time:
5 min
Weight loss

Get expert guidance and a personalized care plan designed around you.
Do Other GLP-1 Medications Cause Constipation?
Mounjaro® is not alone in this side effect; constipation can occur with other GLP-1 receptor agonists and similar medications used to treat diabetes or to help promote weight loss. If you're experiencing constipation from Mounjaro® or any other GLP-1 medication, discussing it with your healthcare provider is crucial. They may suggest ways to mitigate the side effects or consider alternative treatments if necessary.
Understanding the potential side effects of Mounjaro®, including constipation, is important for managing your treatment plan effectively. While constipation can be a bothersome side effect, employing preventative measures and maintaining open communication with your healthcare provider can help manage or minimize its impact. Mounjaro® has shown significant promise in helping individuals lose weight. With time and the right approaches, overcoming unpleasant side effects like constipation is possible so you can continue on your weight loss journey.
Getting Started on Mounjaro® For Weight Loss
With Mochi Health, unlock a new chapter in your health story. Our comprehensive approach includes GLP-1 medications, expert guidance, and a supportive community, all aimed at helping you achieve your weight loss goals. Membership includes virtual visits with a Mochi provider, appointments with a registered dietitian, and 24/7 support. Wondering about the cost of brand-name medications? It depends on your insurance, but at Mochi Health, we provide compounded options that offer both safety and affordability. With affordable compounded semaglutide and tirzepatide delivered directly to your door, managing your health has never been more convenient. See if you're eligible and begin your journey today.
References:
Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A; SURMOUNT-1 Investigators. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022 Jul 21;387(3):205-216. doi: 10.1056/NEJMoa2206038. Epub 2022 Jun 4. PMID: 35658024.
Samms, R. J., Coghlan, M. P., & Sloop, K. W. (2020). How May GIP Enhance the Therapeutic Efficacy of GLP-1?. Trends in endocrinology and metabolism: TEM, 31(6), 410–421. https://doi.org/10.1016/j.tem.2020.02.006
Mounjaro® Compared to Other T2D Medicines | Mounjaro® (Tirzepatide), Eli Lilly and Company, Mounjaro®.lilly.com/what-is-mounjaro/t2d-competitors.
Anderson, J. W., Baird, P., Davis, R. H., Jr, Ferreri, S., Knudtson, M., Koraym, A., Waters, V., & Williams, C. L. (2009). Health benefits of dietary fiber. Nutrition reviews, 67(4), 188–205. https://doi.org/10.1111/j.1753-4887.2009.00189.x
Bellini, M., Tonarelli, S., Barracca, F., Rettura, F., Pancetti, A., Ceccarelli, L., Ricchiuti, A., Costa, F., de Bortoli, N., Marchi, S., & Rossi, A. (2021). Chronic Constipation: Is a Nutritional Approach Reasonable?. Nutrients, 13(10), 3386. https://pubmed.ncbi.nlm.nih.gov/34684388/
Iovino P., Chiarioni G., Bilancio G., Cirillo M., Mekjavic I.B., Pisot R., Ciacci C. New onset of constipation during long-term physical inactivity: A proof-of-concept study on the immobility-induced bowel changes. PLoS ONE. 2013;8:e72608. doi: 10.1371/journal.pone.0072608.
This post was written by our team of health writers for informational purposes only and does not constitute medical advice. Always consult your doctor or healthcare provider for personalized guidance regarding your health. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® and their delivery device are registered trademarks. Mochi Health is a telehealth clinic that offers prescriptions for these products by medical necessity only as determined by a licensed health provider.
Share this post
Weight loss
More articles















